首页> 外国专利> SYNERGISTIC ACTIVATION OF REGULATORY ELEMENTS BY REL PROTEINS AND A STEROID RECEPTOR

SYNERGISTIC ACTIVATION OF REGULATORY ELEMENTS BY REL PROTEINS AND A STEROID RECEPTOR

机译:REL蛋白质和甾体受体对调节元素的协同​​激活。

摘要

Interaction of Rel proteins and steroid receptors is known to result in repression of target genes. Here we describe the discovery of a new mechanism in which Rel proteins and steroid receptors act synergistically to activate a regulatory element. This mechanism is shown to influence the expression of the brain-specific 5HT1A receptor wherein the estrogen receptor acts synergistically with the Nuclear Factor kappa B to enhance the activity of the promoter for the 5HT1A receptor gene. In addition, synergistic effects of Rel proteins with the mineralocorticoid receptor were observed, showing that synergism with Rel proteins may be expected for other steroid receptors as well. The synergism between Rel proteins and estrogen receptor or mineralocorticoid receptor provides a tool for the development of compounds that interact with the estrogen or mineralocorticoid receptor in such a way that only the synergistic effect is modulated whereas other effects are left intact. Such compounds would be invaluable for the development of medicaments for the treatment of diseases of the central nervous or cardiovascular system and other disorders in which Rel proteins play a role.
机译:已知Rel蛋白和类固醇受体的相互作用导致靶基因的阻遏。在这里,我们描述了一种新机制的发现,其中Rel蛋白和类固醇受体协同作用来激活调节元件。已显示该机制影响脑特异性5HT1A受体的表达,其中雌激素受体与核因子κB协同作用,以增强5HT1A受体基因的启动子活性。另外,观察到Rel蛋白与盐皮质激素受体的协同作用,表明与Rel蛋白的协同作用也可预期用于其他类固醇受体。 Rel蛋白与雌激素受体或盐皮质激素受体之间的协同作用为开发与雌激素或盐皮质激素受体相互作用的化合物提供了一种工具,使得仅调节协同作用,而其他作用保持完整。这样的化合物对于开发用于治疗中枢神经或心血管系统疾病以及Rel蛋白起作用的其他疾病的药物将是无价的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号